Following a full day’s deliberations, a federal jury in Raleigh, North Carolina, returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation after a seven-day trial involving Aredia and Zometa, medicines used to prevent the devastating…
The U.S. District Court for the Western District of North Carolina granted a motion filed by Firm client Novartis Pharmaceuticals Corporation (“NPC”) to preclude punitive damages law in this case involving claims that the drugs Aredia…
Judge Graham Mullen ruled on Novartis’s Daubert motion in a Zometa case, excluding large portions of the opinions of Dr. Suzanne Parisian. Lemons v. Novartis Pharm. Corp., No. 3:08-cv-00361 (W.D.N.C. Order March 21, 2012). Dr. Parisian…
After two and a half days of trial, the plaintiff in Brown v. Novartis Pharm. Corp., No. 7:08-CV-00130-FL (E.D.N.C.), agreed to dismiss with prejudice his claims against Firm client Novartis Pharmaceuticals Corporation (“NPC”). The plaintiff is…
A Magistrate Judge in the U.S. District Court for the Eastern District of North Carolina recommended that the motion of Novartis Pharmaceuticals Corporation (“NPC”) to apply New Jersey law to the issue of punitive damages be…
